Search Results
Oct 30, 2025, 16:15 ET NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
Prof. Michel Revel, Director and Chief Scientific Officer; Alexander Zwyer, Director; Kfir Molakandov, PhD, Vice President of R&D; Prof. Ariel Revel, MD, Medical Director; and Eric Konofal, MD, PhD, Head of the DOXA Program. The board of directors of NewcelX includes Ronen Twito, Prof. Michel Revel,
More news about: NewCelX Ltd.; NLS Pharmaceutics Ltd.; Kadimastem Ltd.
Oct 30, 2025, 14:37 ET NO COPAY PHYSICAL THERAPY PROGRAM ASSOCIATED WITH LOWER DOWNSTREAM IMAGING, INJECTION, AND SURGERY FOR MUSCULOSKELETAL CONDITIONS, ACCORDING TO A NEW JOINT STUDY FROM ATI PHYSICAL THERAPY AND DUKE CLINICAL RESEARCH INSTITUTE
costs, to early physical therapy are effective for treatment of musculoskeletal conditions and results in lower costs," said co-author Chuck Thigpen, PhD, PT, ATC, Chief Clinical & Strategy Officer for ATI Physical Therapy. "Our results add to the literature that clearly shows early access to physical
More news about: ATI Physical Therapy
Oct 30, 2025, 12:45 ET Healthcare Providers Describe Exclusive Human Milk Diet as 'Critical' Need for Premature Infants
Kate Tauber, MD, MA (Clinical Proceedings Chair) Carlie Austin, BSN, RN, PhD Candidate Jenny Fox, MD, MPH, IBCLC Dan Stewart, MD
More news about: National Coalition for Infant Health
Oct 30, 2025, 11:00 ET Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 40th Anniversary Annual Meeting
first-in-class TCR β-chain-targeted bifunctional antibody, in tissue-agnostic, TMB-H patients from STARt-001, a Phase 1/2 trialAurélien Marabelle, MD, PhD – Gustave Roussy & Paris Saclay UniversitySession 104: Clinical Oral Abstract Session – Friday, Nov. 7, 2025 – 11:30 a.m. ET
More news about: Society for Immunotherapy of Cancer (SITC)
Oct 30, 2025, 10:00 ET QDCME MARKS ONE-YEAR ANNIVERSARY WITH LAUNCH OF CURATED AI AND MICROLEARNING PLATFORMS ADDRESSING ONCOLOGY AND PRIMARY CARE EDUCATIONAL NEEDS
academic settings. "Our dual focus on oncology and primary care reflects how medicine is practiced today," said Chelsey Goins, PhD, Vice President, Managing Scientific Director at QDcme. "By combining adaptive AI learning for oncologists with microlearning for NPs and PAs and extending
More news about: QDcme LLC
Oct 30, 2025, 09:15 ET UNA BECA DE INVESTIGACIÓN POR VALOR DE $4.1 MILLONES SERVIRÁ PARA MEJORAR LA COORDINACIÓN DE LA ATENCIÓN MÉDICA DEL ASMA INFANTIL EN LAS ESCUELAS LOCALES
PhD, 112 estudiantes en programa combinado de MD y PhD, y aproximadamente
More news about: Montefiore Health System
Oct 30, 2025, 08:30 ET Using Acceleration Levers to Expedite Late Phase CMC Programs for Therapeutic Proteins, Upcoming Webinar Hosted by Xtalks
learn how to apply acceleration levers in late phase CMC to reduce timelines and improve program efficiency. Join Ian Brown, PhD, Senior Director Process Characterization and Process Validation Sciences,
More news about: Xtalks
Oct 30, 2025, 08:30 ET Biomarker-Driven Therapy Launch Strategies for Global Success, Upcoming Webinar Hosted by Xtalks
this webinar to learn how to launch biomarker-driven therapy with global access and diagnostic success. Join Gudrun Baenfer, PhD, Client Relations and Business Expansion Manager, Peri and Post Approval Services,
More news about: Xtalks
Oct 30, 2025, 08:30 ET Michael Berenbaum, Ph.D., to be Honored at Dallas Holocaust and Human Rights Museum Annual Hope for Humanity Dinner
multimedia:https://www.prnewswire.com/news-releases/michael-berenbaum-phd-to-be-honored-at-dallas-holocaust-and-human-rights-museum-annual-hope-for-humanity-dinner-302598994.html
More news about: Dallas Holocaust and Human Rights Museum
Oct 30, 2025, 08:05 ET National Sleep Foundation's New Study Reveals Parents Rank Getting Enough Sleep to Drive Alert as Most Important to Keep Family Safe
"Our new data reveal that drowsy driving isn't just an individual behavior, it's a family sleep health issue," said Joseph Dzierzewski, PhD, Senior Vice President of Research and Scientific Affairs at NSF. "Parents juggling multiple children's schedules, early school drop-offs, and extracurriculars
More news about: National Sleep Foundation
Oct 30, 2025, 08:00 ET GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
Neurosurgeon Ali Jalali, MD, PhD, Neurosurgeon Snehal Desai, MD, Radiation Oncologist Zaid Siddiqui, MD, Radiation Oncologist Daniel Hamstra, MD, PhD, Radiation Oncologist
More news about: GT Medical Technologies
Oct 30, 2025, 08:00 ET Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025
2 Presenter: Xingyue Huang, PhD Session Title: CKD: Biomarkers and Emerging Tools for Diagnosis and Monitoring
More news about: Mallinckrodt plc
Oct 30, 2025, 07:00 ET CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
[email protected] Investor Relations Contact:Aman Patel, CFA & Adanna G. Alexander, PhDICR [email protected]
More news about: Cytosorbents Corp
Oct 30, 2025, 04:00 ET AbolerIS Pharma Appoints Seasoned Life-Sciences Executive Philippe Alen as Chief Business Officer
and financing efforts as we advance our pipeline through the clinic and toward patients in need." Philippe holds a PharmD and PhD from the University of Leuven and an MBA from Drexel University, Philadelphia. His broad industry experiences span roles of increasing responsibility
More news about: AbolerIS Pharma
Oct 29, 2025, 18:34 ET CREATE Medicines Unveils All-RNA T-Cell Engineering Platform: RetroT Enables Site-Specific, Durable CAR integration In Vivo
that programs T cells in vivo with site-specific, durable gene insertion while maintaining the flexibility to re-dose," said Robert Hofmeister, PhD, Chief Scientific Officer of CREATE Medicines. "When combined with our targeted LNP delivery and human-validated mRNA platform, RetroT provides
More news about: CREATE Medicines, Inc.
Oct 29, 2025, 16:20 ET Illume Fertility Unveils Cutting-Edge Research Advancing IVF and Laboratory Innovation at ASRM 2025
Continuous Culture Medium in Supporting Oocytes and Spermatozoa During Conventional Insemination," was led by Erin E. DiPietro, PhD, with senior author Dara S. Berger, PhD, MPH, MS. The study evaluated the use of a low lactate, low glucose medium throughout oocyte handling and conventional insemination.
More news about: Illume Fertility
Oct 29, 2025, 16:03 ET PIH Health Announces Fiscal Year 2025-2026 Board of Directors
Health, Inc. (PIH Health) is pleased to announce its fiscal year 2025-2026 Board of Directors. The Board officers are as follows: Charlotte Weaver PhD RN, Chair; Alex Alvarez, Vice Chair; Paul Treinen, Secretary; and William Roth, Treasurer.
More news about: PIH Health
Oct 29, 2025, 14:30 ET Accelerating Radiopharmaceutical Therapy with Translational Tools, Upcoming Webinar Hosted by Xtalks
Perceptive, Mike Batey, Senior Director, SMS Discovery; and Julian Goggi, PhD, Director, Discovery Research, for the live webinar on Friday, November 14, 2025, at 9am EST (3pm CET/EU-Central). For more information,
More news about: Xtalks
Oct 29, 2025, 14:30 ET Boost Participant Recruitment with Precision Feasibility and RWD, Upcoming Webinar Hosted by Xtalks
Citeline, Skye Hodson, PhD, VP Clinical Solutions; and Lyndsay Stahl, VP, Global Head of Patient Engagement and Recruitment, for the live webinar on Monday, November 17, 2025,
More news about: Xtalks
Oct 29, 2025, 14:00 ET Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
transplant community with Dr. Robert Montgomery, MD, PhD, NYU Langone Transplant Institute, and Dr. Matthew Cooper, MD, Medical College of Wisconsin, followed by a Q&A session. About Robert Montgomery, MD, PhD Dr. Robert
More news about: Hansa Biopharma AB
Oct 29, 2025, 13:57 ET Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
transplant community with Dr. Robert Montgomery, MD, PhD, NYU Langone Transplant Institute, and Dr. Matthew Cooper, MD, Medical College of Wisconsin, followed by a Q&A session. About Robert Montgomery, MD, PhD Dr. Robert
More news about: Hansa Biopharma AB
Oct 29, 2025, 13:28 ET Avobis Bio Presents Positive Primary Analysis Results from the Randomized Multicenter STOMP2 Clinical Trial at a Plenary Session of the American College of Gastroenterology's Annual Scientific Meeting
this investigational therapy for such a severe and debilitating manifestation of Crohn's disease with limited treatment options," said Tiffany Brown, PhD, Chief Executive Officer of Avobis Bio. "The favorable trial results, along with FDA's recent RMAT designation, uniquely position Avobis to expedite
More news about: Avobis Bio
Oct 29, 2025, 12:00 ET UCB opens applications for 2026 UCB Myasthenia Gravis Scholarship™
"The UCB U.S. Myasthenia Gravis Scholarship™ is dedicated to supporting people impacted by myasthenia gravis," said Kimberly Moran, PhD, MBA, SVP & Head, US Rare Diseases. "It's one of the many ways UCB is committed to empowering patients and caregivers—beyond medicine—through meaningful
More news about: UCB
Oct 29, 2025, 10:36 ET Lycored presenta su nueva tecnología VAS en SupplySide Global.
exhibiciones: Escuche a Elizabeth Tarshish, PhD, responsable de Producto y Ciencia, hablar sobre "Del tomate a la transformación: El viaje del licopeno hacia la salud", donde abordará la ciencia de
More news about: Lycored
Oct 29, 2025, 10:31 ET Lycored stellt neue VAS-Technologie auf der SupplySide Global vor
Clean-Label-Inhaltsstoffen durch verschiedene Aktivierungen und Ausstellungen glänzt: Elizabeth Tarshish, PhD, Leiterin der Abteilung Produkt und Wissenschaft, spricht über „Tomato to Transformation: Lycopen's Health Journey", die sich mit der Wissenschaft der
More news about: Lycored